Moderna aims to license combined flu and Covid jab in 2025
Moderna has announced its combined flu and Covid vaccine has generated strong immune responses in early-stage trials.
Interim results from its phase 1/2 studies found the vaccine (mRNA-1083) generated antibody levels similar to or greater than flu vaccines as well as similar results to the standalone Moderna Covid jab.
Related Article: Beyond the scales: reframing eating disorder recognition in primary care
It plans to start a phase 3 trial of the combined vaccine in adults over the age of 50 later this year, a statement from the company said.
They will be aiming for regulatory approval in 2025, a spokesperson said.
The early tests suggested the vaccine appeared effective against A and B strains of flu when compared with widely used flu vaccines produced by Sanofi and GSK.
It was also found to be safe and tolerated with rates of adverse effects similar to those that had been reported with the Moderna Covid-19 vaccine.
Related Article: Sharp rise in diabetes cases prompts call for better postnatal support
Stéphane Bancel, chief executive officer at Moderna said: ‘Flu and Covid-19 represent a significant seasonal burden for individuals, providers, healthcare systems and economies.
‘Combination vaccines offer an important opportunity to improve consumer and provider experience, increase compliance with public health recommendations, and deliver value for healthcare systems.’
Related Article: Novo Nordisk launch new 7.2mg single-dose Wegovy pen
Keep your clinical knowledge up to date with The Pharmacist
Extend your learning and record your learning outcomes
Have your say
Please add your comment in the box below. You can include links, but HTML is not permitted. Please note that comments are not moderated before publication and the views expressed are those of the user and do not reflect the views of The Pharmacist. Remember that submission of comments is governed by our Terms and Conditions. You can also read our full guidelines on article comments here – but please be aware that you are legally liable for any libellous or offensive comments that you make. If you have a complaint about a comment or are concerned that a comment breaches our terms and conditions, please use the ‘Report this comment’ function to alert our web team.